Allianz Sinks to 115th in Global Market Cap Ranking as Shares Trade Near All-Time High
Published on 07/05/2026 at 07:13 | Redaktion boerse-global.de
Allianz finds itself in an odd position these days. Its stock is hovering just a whisker below a fresh all-time high, yet the Munich-based insurer has fallen out of the exclusive club of the world’s 100 most valuable publicly traded companies. A new study from consultancy EY shows the group slipped from 98th place at the start of the year to 115th at the halfway mark, its market capitalisation of $174bn no longer enough to keep it in the elite.
The slide reflects how decisively the global equity landscape is being reshaped by the US tech tidal wave. North America now accounts for 56 of the companies in the top 100, while China trails far behind with 12. Germany, which once boasted seven members in that ranking, is down to just one: Siemens, occupying 72nd spot. SAP also tumbled out of the top 100, falling just ahead of Allianz. On the brighter side, Siemens Energy and Infineon both doubled their market valuations this year, riding the same wave that is lifting their US peers.
The gap between Allianz’s dwindling global standing and its buoyant local performance is stark. The stock closed Friday at €418.70, barely 0.64% below its 52-week high of €421.40, set on 3 July. Since the start of the year it has risen 7.72%. Yet the analyst community is deeply split on where the shares go from here. The most bullish call comes from Berenberg, which reiterates a “Buy” rating and a price target of €684 — implying 67% upside from recent levels near €408. At the other end of the spectrum, UBS sees fair value at €390, RBC Capital Markets at €400, and Goldman Sachs at €450. The consensus average sits at roughly €424, barely above the current price.
Should investors sell immediately? Or is it worth buying Allianz?
Berenberg’s Michael Huttner argues that Europe’s large composite insurers, including Allianz, Axa, Generali and Zurich, are still priced as if recent improvements in their business models and financial metrics have not happened. He points to a forward price-to-earnings ratio of around 12 for 2028, which he believes should be closer to 20. That disconnect, in his view, underpins a compelling buying opportunity.
Chart watchers are less convinced. The 14-day relative strength index has climbed to 77.6, flashing a clear overbought signal. The stock sits 7.70% above its 50-day moving average of €388.78 and 11.66% above the 200-day average of €374.98. Over the past month, Allianz has gained 13.28%, and since touching its 52-week low of €334.90 on 1 August 2025, it has recovered 25.02%. Despite the run-up, the rally has been orderly — the annualised 30-day volatility stands at a moderate 13.74% — suggesting no speculative frenzy.
Supporting the bull case on the fundamental side is the company’s capital management. On 25 February, Allianz announced a new share buyback programme of up to €2.5bn, which began on 13 March and is scheduled to conclude by the end of December 2026. The shares repurchased will be cancelled, providing a structural lift to earnings per share. The programme also serves as a signal of how management itself views the stock at near-record levels.
Investors will get the next major data point on 7 August, when Allianz releases its half-year report. Until then, the debate between chartists warning of a pullback and fundamental analysts arguing for substantial upside is likely to sharpen — a tension that mirrors the broader divergence between the company’s shrinking global footprint and its local share-price momentum.
Ad
Allianz Stock: New Analysis - 5 July
Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
